Follow-On Proteins Draft Guidance Will Be Followed By Third Public Meeting
Executive Summary
FDA will hold a third public forum on follow-on proteins shortly after the release of a draft guidance on the topic, Acting Deputy Commissioner of Operations Janet Woodcock said Feb. 14
You may also be interested in...
FDA Generic Biologics Short-Term Plan Includes Immunogenicity Document
Immunogenicity and chemistry of follow-on biologics will be among the first issues FDA tackles in documents issued on the topic, Acting Commissioner Lester Crawford said at the Generic Pharmaceutical Association's annual meeting in Boca Raton, Fla
FDA Generic Biologics Short-Term Plan Includes Immunogenicity Document
Immunogenicity and chemistry of follow-on biologics will be among the first issues FDA tackles in documents issued on the topic, Acting Commissioner Lester Crawford said at the Generic Pharmaceutical Association's annual meeting in Boca Raton, Fla
Novartis Seeks To Be Generics “Powerhouse” With Eon, Hexal Acquisitions
Novartis expects the addition of Eon Labs and Hexal AG to its Sandoz division to create a generic drug "powerhouse" that will play a major role in the emerging "authorized" generics and follow-on biologics markets